Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2013-12-09 Earnings Release
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Half Yearly Report
Earnings Release Classification · 100% confidence The document explicitly states 'Interim Results for the six months ended 31 October 2013' and provides detailed financial figures (Operating loss, Net loss) and operational updates for a six-month period. This content aligns perfectly with the definition of an Interim/Quarterly Report. The RNS number suggests it was also released via a regulatory news service, but the core content is the comprehensive interim financial report, making 'IR' the most specific classification over 'RNS'. The document length (25,781 chars) confirms it is a full report, not just an announcement of a report (RPA). H1 2013
2013-12-09 English
Re Agreement with Ichor
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content discusses an extension to a commercial option agreement, the exercise of share options by a counterparty (Ichor), and the subsequent application for admission of new ordinary shares to trading. This involves changes in capital structure (share issuance) and contractual agreements, but the primary function of the document, as indicated by the RNS header and the nature of the announcement (a material corporate event update), fits best under the general regulatory announcement category. Since it specifically details a share issuance/capital change related to an agreement, it touches upon 'CAP' and 'SHA', but the format and source (RNS) strongly suggest a general regulatory filing. Given the options, 'RNS' (Regulatory Filings) is the most appropriate catch-all for a standard RNS announcement detailing corporate actions, especially when the action is complex (option extension + share issuance). It is not a full report (10-K, IR), an earnings release (ER), or a dedicated capital raise announcement (CAP), but rather a notification of an event via the regulatory wire.
2013-11-18 English
AGM Statement
AGM Information Classification · 99% confidence The document explicitly states 'RNS Number : 0551S' and 'Results of AGM'. It confirms that 'all resolutions proposed at the Annual General Meeting held today were duly passed.' This content directly relates to the outcomes and information disseminated concerning the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a presentation (IP) or a proxy solicitation (PSI), but a direct announcement of the results of the meeting.
2013-11-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document explicitly mentions 'RNS Number' and details share transactions by directors ('Lindy Durrant and Richard Goodfellow each sold 100,000 shares'). This directly corresponds to the definition of Director's Dealing (insider trades). The presence of the RNS identifier suggests it was filed via the London Stock Exchange's news service, but the core content is about director transactions. Therefore, the most specific classification is DIRS.
2013-10-22 English
Group of companies' accounts made up to 2013-04-30
Regulatory Filings
2013-10-17 English
Holding(s) in Company
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 4161Q' and contains the standard structure of a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This form reports changes in major shareholdings, specifically detailing the acquisition or disposal of voting rights and the resulting percentage of ownership (17.86%). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2013-10-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.